BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20685653)

  • 21. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.
    Fortin A; MacLaurin JG; Arbour N; Cregan SP; Kushwaha N; Callaghan SM; Park DS; Albert PR; Slack RS
    J Biol Chem; 2004 Jul; 279(27):28706-14. PubMed ID: 15105421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.
    Hong S; Pusapati RV; Powers JT; Johnson DG
    Cell Cycle; 2006 Apr; 5(8):801-3. PubMed ID: 16582589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.
    Liontos M; Niforou K; Velimezi G; Vougas K; Evangelou K; Apostolopoulou K; Vrtel R; Damalas A; Kontovazenitis P; Kotsinas A; Zoumpourlis V; Tsangaris GT; Kittas C; Ginsberg D; Halazonetis TD; Bartek J; Gorgoulis VG
    Am J Pathol; 2009 Jul; 175(1):376-91. PubMed ID: 19541929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T; Chaussepied M; Oren M; Ginsberg D
    Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic regulation of Rad51 by E2F1 and p53 in prostate cancer cells upon drug-induced DNA damage under hypoxia.
    Wu M; Wang X; McGregor N; Pienta KJ; Zhang J
    Mol Pharmacol; 2014 Jun; 85(6):866-76. PubMed ID: 24627085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision.
    Sun CY; Zhang XP; Wang W
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jab1 is a specificity factor for E2F1-induced apoptosis.
    Hallstrom TC; Nevins JR
    Genes Dev; 2006 Mar; 20(5):613-23. PubMed ID: 16481464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
    Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
    J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
    Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
    EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
    Cassimere EK; Pyndiah S; Sakamuro D
    Cell Death Differ; 2009 Dec; 16(12):1641-53. PubMed ID: 19629135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E2F1 inhibits MDM2 expression in a p53-dependent manner.
    Tian X; Chen Y; Hu W; Wu M
    Cell Signal; 2011 Jan; 23(1):193-200. PubMed ID: 20837136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysine methylation regulates E2F1-induced cell death.
    Kontaki H; Talianidis I
    Mol Cell; 2010 Jul; 39(1):152-60. PubMed ID: 20603083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do negative feedback oscillations drive variations in the length of the tumor cell division cycle?
    Baguley BC; Marshall E
    Oncol Res; 2005; 15(6):291-4. PubMed ID: 16408693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the G1/S transition phase in mesangial cells by E2F1.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein.
    Hossain S; Iwasa H; Sarkar A; Maruyama J; Arimoto-Matsuzaki K; Hata Y
    Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29891515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.
    Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T
    Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of E2F1 by BRCT domain-containing protein TopBP1.
    Liu K; Lin FT; Ruppert JM; Lin WC
    Mol Cell Biol; 2003 May; 23(9):3287-304. PubMed ID: 12697828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.